Literature DB >> 6367975

A double-blind trial of clonazepam in benign essential tremor.

C Thompson, A Lang, J D Parkes, C D Marsden.   

Abstract

Clonazepam has been reported to be of some value in the treatment of benign essential tremor in open trials. The efficacy of clonazepam was evaluated in a double-blind placebo-controlled study using up to 4 mg/day. By a variety of objective measures, clonazepam was not found to be an effective form of therapy.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6367975     DOI： 10.1097/00002826-198403000-00004

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


  21 in total

1.  Essential Tremor.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

Review 2.  Essential tremor.

Authors:  Joaquim Jos Ferreira; Cristina Sampaio
Journal:  BMJ Clin Evid       Date:  2007-05-01

Review 3.  Pharmacotherapy of essential tremor : an overview of existing and upcoming agents.

Authors:  Kelly E Lyons; Rajesh Pahwa
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  A patient with tremor, part 2: from diagnosis to treatment.

Authors:  Hrishikesh Kumar; Mandar Jog
Journal:  CMAJ       Date:  2011-08-15       Impact factor: 8.262

5.  Orthostatic tremor: diagnostic entity or variant of essential tremor?

Authors:  L Cleeves; J Cowan; L J Findley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

6.  Diagnosis and management of essential tremor and dystonic tremor.

Authors:  Alexandre Gironell; Jaime Kulisevsky
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

Review 7.  Benefits and risks of pharmacological treatments for essential tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa; Cynthia L Comella; Mahmood S Eisa; Rodger J Elble; Stanley Fahn; Joseph Jankovic; Jorge L Juncos; William C Koller; William G Ondo; Kapil D Sethi; Matthew B Stern; Caroline M Tanner; Ron Tintner; Ray L Watts
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study.

Authors:  Davide Uccellini; G Grampa; I La Spina; D Nasuelli; I Neromante; L Politini; F Reverberi; D Porazzi; V Carli; G Camardese
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570

9.  Overview of essential tremor.

Authors:  Theresa A Zesiewicz; Abinaya Chari; Israt Jahan; Amber M Miller; Kelly L Sullivan
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

Review 10.  Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association.

Authors:  Mario Zappia; Alberto Albanese; Elisa Bruno; Carlo Colosimo; Graziella Filippini; Paolo Martinelli; Alessandra Nicoletti; Graziella Quattrocchi; Giovanni Abbruzzese; Alfredo Berardelli; Roberta Allegra; Maria Stella Aniello; Antonio E Elia; Davide Martino; Daniela Murgia; Marina Picillo; Giovanna Squintani
Journal:  J Neurol       Date:  2012-08-11       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.